MORE INCLUSIVE RESEARCH

The Data Diversity Initiative

The data in biomedical research is often derived from nonrepresentative patient datasets, which has serious consequences for research and treatment, such as understanding disease risk or drug effectiveness in different populations. BenevolentAI’s Data Diversity Initiative exists to propose tangible solutions to this urgent issue, raise awareness and act as a forum to drive change.

81%

of participants in genome-wide association studies are of European descent.

40%

of all trials exclude the elderly.

One-fifth

of new drugs approved between 2008 and 2013 showed racial differences in drug response.

22–42%

of articles in major publications omit the sex of animal subjects.

REsources

Learn more about Data Diversity

Data Diversity: Ten practical approaches to acquiring the right datasets Part 1

Oct 20, 2020

Data Diversity: Ten practical approaches to acquire the right datasets Part 2

Oct 20, 2020

The Diversity Analysis Tool: Towards better Diversity in Data for Precision Medicine

Sep 22, 2020

How historically neglecting sex differences has impacted women’s health

Mar 8, 2020

Medical data: the key to unlocking the true potential of AI in healthcare

Mar 3, 2020

Data Diversity Initiative: Tackling the Medical Research Data Gap

Feb 25, 2020

Mind the gap: the diversity issue in medical research.

Oct 6, 2019